Ikgdar 100 mg Injection
  1. Home
  2. Pharma Products
  3. Cipla Ltd
  4. Ikgdar 100 mg Injection

Ikgdar 100 mg Injection

Ikgdar 100 mg Injection contains rituximab 100 mg, a monoclonal antibody used for certain blood cancers and autoimmune disorders. It is administered by intravenous infusion under the supervision of a healthcare professional. Rituximab targets CD20-positive B cells and helps reduce abnormal B-cell activity.

BUY NOW

Category

Ikgdar 100 mg Injection is used in conditions such as non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and certain blood-vessel disorders. Rituximab binds to the CD20 antigen on B cells and supports their removal through immune-mediated mechanisms. The dose and infusion schedule are determined by the treating specialist according to the condition and treatment protocol. Medical supervision during administration is important because infusion-related reactions may occur.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 100 mg
Dosage Form Injection / Solution for Infusion
Route of Administration Intravenous Infusion
Pack Size 10 mL in 1 Vial
Manufacturer/Marketer Cipla Ltd.

Product Also Known As

Ikgdar 100 mg Injection, Ikgdar 100 Injection, Ikgdar Rituximab Injection, Rituximab 100 mg Injection, Rituximab 100 mg/10 mL Injection, Rituximab Monoclonal Antibody Injection